CD276 and glioblastoma: Of note, Tachi et al. demonstrated that B7H3-targeting, CB-derived CAR-NK cells suppressed glioblastoma tumour growth and extend survival in xenograft models using patient-derived GBM cells, which accurately reflected characteristics of patient tumours [100].